Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy
Public ClinicalTrials.gov record NCT04984876. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 52 Week, Multi-center, Randomized, Double-blind Placebo-controlled Study to Assess the Clinical Efficacy and Safety of Ligelizumab (QGE031) in Decreasing the Sensitivity to Peanuts in Patients With Peanut Allergy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a 52-week, Phase 3 multi-center, randomized, double-blind and placebo-controlled study to assess the safety and clinical efficacy of two dosing regimens of ligelizumab (240 mg and 120 mg) SC q4w (subcutaneous injection every 4 weeks) in participants with a medically confirmed diagnosis of Immunoglobulin E (IgE) mediated peanut allergy.
Study identification
- NCT ID
- NCT04984876
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 211 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 7, 2021 (Actual)
- Primary completion
- Nov 27, 2023 (Actual)
- Completion
- Nov 27, 2023 (Actual)
- Last update posted
- Apr 29, 2025
2021 – 2023
United States locations
- U.S. sites
- 29
- U.S. states
- 19
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allervie Clinical Research | Birmingham | Alabama | 35209 | — |
| Allergy and Immunology Associates | Scottsdale | Arizona | 85251 | — |
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| Allergy and Asthma Associates of Santa Clara Vally Center | San Jose | California | 95117 | — |
| Allergy and Asthma Clinical Research Inc | Walnut Creek | California | 94598 | — |
| UCHealth Outpatient Pavilion | Aurora | Colorado | 80045 | — |
| Asthma and Allergy Associates P C | Colorado Springs | Colorado | 80907 | — |
| Colorado Allergy and Asthma Ctr PC | Denver | Colorado | 80230 | — |
| Univ of South Florida Asthma Allergy and Immunology CRU | Tampa | Florida | 33613 | — |
| Childrens Healthcare of Atlanta | Atlanta | Georgia | 30342 | — |
| Atlanta Allergy and Asthma Clinic | Marietta | Georgia | 30062 | — |
| Ann and Robert H Lurie Childrens Hospital of Chicago | Chicago | Illinois | 60611 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Family Allergy and Asthma | Louisville | Kentucky | 40217 | — |
| Johns Hopkins Childrens Center | Baltimore | Maryland | 21287 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Boston Childrens Hospital | Boston | Massachusetts | 02215 | — |
| University of Michigan Clinical Trials Office | Ann Arbor | Michigan | 48109 | — |
| Respiratory Medicine Research Institute of Michigan | Ypsilanti | Michigan | 48197 | — |
| UBMD Pediatrics | Buffalo | New York | 14203 | — |
| Northwell Health | New York | New York | 10028 | — |
| Mt Sinai Medical Center | New York | New York | 10029-6574 | — |
| University Of NC At Chapel Hill | Chapel Hill | North Carolina | 27599 9500 | — |
| Cincinnati Childrens Hospital MC | Cincinnati | Ohio | 45229-3039 | — |
| Bernstein Clinical Research Center | Cincinnati | Ohio | 45231 | — |
| Childrens Hospital Of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75235 | — |
| Texas Childrens Hospital | Houston | Texas | 77030 | — |
| Seattle Allergy and Asthma Rsch | Seattle | Washington | 98115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04984876, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2025 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04984876 live on ClinicalTrials.gov.